Webster Bank’s iShares Biotechnology ETF IBB Stock Holding History

Webster Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Sell	6,241 -225	-3%	-$38.7K	0.1%	120
2026 Q1	$1.09M	Sell	6,466 -10	-0.2%	-$1.71K	0.1%	117
2025 Q4	$1.09M	Buy	6,476 +62	+1%	+$10.1K	0.1%	115
2025 Q3	$926K	Hold	6,414	–	–	0.09%	120
2025 Q2	$811K	Hold	6,414	–	–	0.08%	128
2025 Q1	$820K	Hold	6,414	–	–	0.09%	130
2024 Q4	$848K	Sell	6,414 -650	-9%	-$91.4K	0.09%	126
2024 Q3	$1.03M	Sell	7,064 -250	-3%	-$36.2K	0.11%	118
2024 Q2	$1M	Hold	7,314	–	–	0.11%	112
2024 Q1	$1M	Sell	7,314 -527	-7%	-$72K	0.11%	116
2023 Q4	$1.07M	Hold	7,841	–	–	0.13%	107
2023 Q3	$959K	Hold	7,841	–	–	0.13%	106
2023 Q2	$995K	Sell	7,841 -480	-6%	-$62.4K	0.13%	107
2023 Q1	$1.07M	Sell	8,321 -450	-5%	-$58.9K	0.14%	108
2022 Q4	$1.15M	Hold	8,771	–	–	0.16%	97
2022 Q3	$1.03M	Sell	8,771 -400	-4%	-$49.7K	0.15%	101
2022 Q2	$1.08M	Sell	9,171 -150	-2%	-$17.8K	0.15%	103
2022 Q1	$1.21M	Sell	9,321 -230	-2%	-$30K	0.14%	106
2021 Q4	$1.46M	Hold	9,551	–	–	0.15%	98
2021 Q3	$1.54M	Buy	9,551 +180	+2%	+$30.3K	0.17%	92
2021 Q2	$1.53M	Hold	9,371	–	–	0.17%	98
2021 Q1	$1.41M	Sell	9,371 -313	-3%	-$49.7K	0.16%	104
2020 Q4	$1.47M	Sell	9,684 -2	-0%	-$286	0.17%	97
2020 Q3	$1.31M	Sell	9,686 -200	-2%	-$27.1K	0.17%	100
2020 Q2	$1.35M	Sell	9,886 -225	-2%	-$28.7K	0.19%	93
2020 Q1	$1.09M	Sell	10,111 -1,020	-9%	-$117K	0.18%	97
2019 Q4	$1.34M	Sell	11,131 -885	-7%	-$98.7K	0.17%	107
2019 Q3	$1.2M	Sell	12,016 -3,700	-24%	-$387K	0.16%	105
2019 Q2	$1.71M	Sell	15,716 -200	-1%	-$21.3K	0.24%	91
2019 Q1	$1.78M	Sell	15,916 -200	-1%	-$21.9K	0.25%	89
2018 Q4	$1.55M	Sell	16,116 -900	-5%	-$95.5K	0.25%	86
2018 Q3	$2.07M	Sell	17,016 -1,350	-7%	-$159K	0.29%	82
2018 Q2	$2.02M	Hold	18,366	–	–	0.29%	81
2018 Q1	$1.96M	Sell	18,366 -270	-1%	-$29.9K	0.28%	90
2017 Q4	$1.99M	Sell	18,636 -750	-4%	-$80.2K	0.27%	89
2017 Q3	$2.16M	Sell	19,386 -330	-2%	-$35.3K	0.31%	82
2017 Q2	$2.04M	Sell	19,716 -120	-0.6%	-$11.8K	0.3%	82
2017 Q1	$1.94M	Sell	19,836 -939	-5%	-$89.9K	0.29%	83
2016 Q4	$1.84M	Sell	20,775 -222	-1%	-$20.2K	0.27%	81
2016 Q3	$2.03M	Sell	20,997 -885	-4%	-$84.2K	0.29%	78
2016 Q2	$1.88M	Sell	21,882 -765	-3%	-$68.6K	0.28%	81
2016 Q1	$1.97M	Sell	22,647 -1,179	-5%	-$105K	0.31%	78
2015 Q4	$2.69M	Sell	23,826 -1,200	-5%	-$130K	0.43%	59
2015 Q3	$2.53M	Sell	25,026 -981	-4%	-$118K	0.47%	54
2015 Q2	$3.2M	Sell	26,007 -777	-3%	-$93K	0.54%	47
2015 Q1	$3.07M	Sell	26,784 -1,050	-4%	-$116K	0.51%	50
2014 Q4	$2.81M	Sell	27,834 -2,271	-8%	-$221K	0.47%	53
2014 Q3	$2.75M	Sell	30,105 -22,173	-42%	-$1.95M	0.49%	50
2014 Q2	$4.48M	Sell	52,278 -15,528	-23%	-$1.22M	0.77%	28
2014 Q1	$5.34M	Buy	67,806 +174	+0.3%	+$14.5K	0.74%	39
2013 Q4	$5.12M	Sell	67,632 -120	-0.2%	-$8.51K	0.72%	38
2013 Q3	$4.73M	Buy	67,752 +3,705	+6%	+$243K	0.73%	41
2013 Q2	$3.71M	Buy	+64,047	New	+$3.7M	0.47%	64

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Webster Bank's IBB Position: Q2 2026 in Review

Webster Bank reduced its iShares Biotechnology ETF (IBB) stake by 3.5% in Q2 2026, selling an estimated $38.7K and leaving 6,241 shares worth $1.19M. The position accounts for 0.1% of the portfolio, ranked #120.

Webster Bank first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.34M in Q1 2014. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Webster Bank held 6,241 shares of iShares Biotechnology ETF worth $1.19M as of Q2 2026.
Webster Bank sold 225 iShares Biotechnology ETF shares in Q2 2026, an estimated $38.7K.
iShares Biotechnology ETF made up 0.1% of Webster Bank's portfolio in Q2 2026, its #120 holding.
Webster Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
Webster Bank's iShares Biotechnology ETF position peaked at $5.34M in Q1 2014.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.